Immunotherapy Combo Shows Promise in Tough-to-Treat, Early Bladder Cancer

MedPage Today) — Preliminary findings presented at the American Urological Association (AUA) annual meeting showed that the combination of the oncolytic virus therapy cretostimogene grenadenorepvec (CG0070) and pembrolizumab (Keytruda) elicited…
Read More